L01EA03 Nilotinib
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 4 drugs in this drug class.
- 4 prescription (Rx)
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01EA BCR-ABL tyrosine kinase inhibitors 30 drugs
- L01EA03 Nilotinib 4 drugs
- L01EA BCR-ABL tyrosine kinase inhibitors 30 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01 Antineoplastic agents 616 drugs
Active ingredients of the class
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| PMS-Nilotinib | prescription (Rx) |
| Reddy-Nilotinib | prescription (Rx) |
| Tasigna (Novartis Pharmaceuticals Canada, 200 mg, 150 mg) PM | prescription (Rx) |
| Tasigna (Novartis Pharmaceuticals Canada, 50 mg) PM | prescription (Rx) |
Other classes of the same level
- L01EA01 Imatinib 15 drugs
- L01EA02 Dasatinib 6 drugs
- L01EA04 Bosutinib 3 drugs
- L01EA05 Ponatinib 1 drug
- L01EA06 Asciminib 1 drug
Other names of the drug class
- English (United Kingdom): L01EA03 nilotinib
- German: L01EA03 Nilotinib
- German (Austria): L01EA03 Nilotinib
- Italian: L01EA03 NILOTINIB
- Turkish: L01EA03 nilotinib
- Czech: L01EA03 Nilotinib
- Slovak: L01EA03 Nilotinib
- Spanish: L01EA03 Nilotinib
- Dutch: L01EA03 Nilotinib
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01EA03
Ask your doctor or pharmacist for advice.